• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Plasma levels and negative chronotropic effect of metoprolol following single doses of a conventional and sustained-release formulation.

作者信息

Quaterman C P, Kendall M J, Welling P G

出版信息

Eur J Clin Pharmacol. 1979 Mar 26;15(2):97-103. doi: 10.1007/BF00609871.

DOI:10.1007/BF00609871
PMID:436924
Abstract

Plasma levels and associated reduction in exercise-induced tachycardia have been examined following the administration of single doses of metoprolol in conventional and slow-release tablets at different times to six healthy male subjects. The study was carried out in two parts. Initially, the tablets were given at 9 a.m. and the subjects were studied up to 14 h and then at 24 h. Subsequently, the same doses were given at 9 p.m. and the subjects were studied 12-24 h after drug administration (i.e. 9 a.m.-9 p.m. the next day). After giving the slow-release tablets the peak plasma levels were significantly lower but the drug persisted in the plasma at higher levels than after the conventional tablet. However, the beta-blocking effect was comparable from the two dosages. The results obtained for the period 12-24 h after the evening dose differed from the corresponding values after morning administration in that the plasma levels were higher and the beta-blocking effects more marked. Furthermore, the half-life values calculated from these data were significantly longer.

摘要

相似文献

1
Plasma levels and negative chronotropic effect of metoprolol following single doses of a conventional and sustained-release formulation.
Eur J Clin Pharmacol. 1979 Mar 26;15(2):97-103. doi: 10.1007/BF00609871.
2
Plasma levels and negative chronotropic effect of metoprolol following single doses of a conventional and sustained release formulation.
Eur J Clin Pharmacol. 1979 Sep;16(3):219. doi: 10.1007/BF00562065.
3
Plasma levels and pharmacological effects of metoprolol administered as controlled release (Durules) and ordinary tablets in healthy volunteers.美托洛尔控释片(倍他乐克缓释片)和普通片剂在健康志愿者体内的血浆浓度及药理作用
Int J Clin Pharmacol Ther Toxicol. 1980 Jul;18(7):292-7.
4
Maximal exercise power after a single dose of metoprolol and of slow-release metoprolol.单次服用美托洛尔和缓释美托洛尔后的最大运动能力。
Eur J Clin Pharmacol. 1980 Oct;18(3):225-9. doi: 10.1007/BF00563003.
5
Effects on exercise tachycardia during forty-eight hours of a series of doses of atenolol, sotalol, and metoprolol.一系列剂量的阿替洛尔、索他洛尔和美托洛尔在48小时内对运动性心动过速的影响。
Clin Pharmacol Ther. 1981 Mar;29(3):295-302. doi: 10.1038/clpt.1981.39.
6
Pharmacokinetic and pharmacodynamic properties of a new controlled-release formulation of metoprolol: a comparison with conventional tablets.美托洛尔新型控释制剂的药代动力学和药效学特性:与传统片剂的比较。
Eur J Clin Pharmacol. 1988;33 Suppl:S9-14. doi: 10.1007/BF00578406.
7
Slow-release metoprolol in angina pectoris. A comparative study of a cardioselective beta-blocking drug, metoprolol, in ordinary and slow-release tablets (Durules) in the treatment of angina pectoris.缓释美托洛尔治疗心绞痛。一项关于心脏选择性β受体阻滞剂美托洛尔普通片剂与缓释片剂(多索茶碱)治疗心绞痛的对比研究。
Ann Clin Res. 1979 Oct;11(5):199-204.
8
The effects of propranolol, practolol and metoprolol on exercise-induced tachycardia in relation to plasma levels in man.普萘洛尔、心得宁和美托洛尔对人体运动诱发心动过速的影响及其与血浆水平的关系。
Clin Exp Pharmacol Physiol. 1976 Sep-Oct;3(5):473-82. doi: 10.1111/j.1440-1681.1976.tb00625.x.
9
Pharmacokinetic and pharmacodynamic comparison of metoprolol CR/ZOK once daily with conventional tablets once daily and in divided doses.美托洛尔控释/缓释片每日一次与普通片剂每日一次及分次给药的药代动力学和药效学比较。
J Clin Pharmacol. 1990 Feb;30(S2):S17-27. doi: 10.1002/j.1552-4604.1990.tb03491.x.
10
Comparison of the duration of effect of metoprolol and a sustained release formulation of metoprolol (betaloc-SA).美托洛尔与美托洛尔缓释制剂(倍他乐克缓释片)作用持续时间的比较。
Br J Clin Pharmacol. 1981 May;11(5):518-20. doi: 10.1111/j.1365-2125.1981.tb01160.x.

引用本文的文献

1
Maximal exercise power after a single dose of metoprolol and of slow-release metoprolol.单次服用美托洛尔和缓释美托洛尔后的最大运动能力。
Eur J Clin Pharmacol. 1980 Oct;18(3):225-9. doi: 10.1007/BF00563003.
2
A single and multiple dose pharmacokinetic and pharmacodynamic comparison of conventional and slow-release metroprolol.常规释放与缓释美托洛尔的单剂量和多剂量药代动力学及药效学比较。
Eur J Clin Pharmacol. 1980 Feb;17(2):87-92. doi: 10.1007/BF00562615.
3
Comparison of the duration of effect of metoprolol and a sustained release formulation of metoprolol (betaloc-SA).

本文引用的文献

1
Per cent absorbed time plots derived from blood level and/or urinary excretion data.根据血药浓度和/或尿排泄数据得出的吸收百分比-时间曲线图。
J Pharm Sci. 1963 Jun;52:610-1. doi: 10.1002/jps.2600520629.
2
Kinetics of pharmacologic effects.药理效应动力学
Clin Pharmacol Ther. 1966 May-Jun;7(3):362-72. doi: 10.1002/cpt196673362.
3
Combined pharmacokinetic and pharmacodynammc studies in man of the adrenergic beta1-receptor antagonist metoprolol.肾上腺素能β1受体拮抗剂美托洛尔在人体中的药代动力学和药效学联合研究。
美托洛尔与美托洛尔缓释制剂(倍他乐克缓释片)作用持续时间的比较。
Br J Clin Pharmacol. 1981 May;11(5):518-20. doi: 10.1111/j.1365-2125.1981.tb01160.x.
4
The effect of age on the pharmacokinetics of metoprolol and its metabolites.年龄对美托洛尔及其代谢产物药代动力学的影响。
Br J Clin Pharmacol. 1981 Mar;11(3):287-94. doi: 10.1111/j.1365-2125.1981.tb00536.x.
5
Metabolic aspects of maximal exercise performance after slow release metoprolol and after atenolol.缓释美托洛尔和阿替洛尔后最大运动表现的代谢方面
Eur J Clin Pharmacol. 1982 Oct;23(4):283-8. doi: 10.1007/BF00613607.
6
Comparative pharmacological and pharmacokinetic observations on propranolol (long acting formulation) and bendrofluazide administered separately and concurrently to volunteers.对志愿者分别及同时给予普萘洛尔(长效制剂)和苄氟噻嗪的比较药理学和药代动力学观察。
Br J Clin Pharmacol. 1982 Nov;14(5):727-32. doi: 10.1111/j.1365-2125.1982.tb04964.x.
7
Comparison of two long-acting preparations of metoprolol with conventional metoprolol and atenolol in healthy men during chronic dosing.慢性给药期间,健康男性中两种长效美托洛尔制剂与常规美托洛尔及阿替洛尔的比较。
Br J Clin Pharmacol. 1982 Nov;14(5):713-8. doi: 10.1111/j.1365-2125.1982.tb04962.x.
8
Comparison of the pharmacodynamic and pharmacokinetic profiles of single and multiple doses of a commercial slow-release metoprolol formulation with a new Oros delivery system.采用新型渗透泵给药系统的市售缓释美托洛尔制剂单剂量与多剂量的药效学和药代动力学特征比较。
Br J Clin Pharmacol. 1982 Mar;13(3):393-8. doi: 10.1111/j.1365-2125.1982.tb01391.x.
9
Lack of evidence for polymorphism in metoprolol metabolism.美托洛尔代谢中缺乏多态性的证据。
Br J Clin Pharmacol. 1983 Aug;16(2):188-90. doi: 10.1111/j.1365-2125.1983.tb04984.x.
10
Slow release beta-adrenoceptor blocking drugs.缓释β-肾上腺素能受体阻滞剂
J R Coll Physicians Lond. 1983 Apr;17(2):126-32.
Acta Pharmacol Toxicol (Copenh). 1975;36(Suppl 5):31-44. doi: 10.1111/j.1600-0773.1975.tb03320.x.
4
Comparative bioavailability and effect studies on metoprolol administered as ordinary and slow-release tablets in single and multiple doses.美托洛尔普通片与缓释片单剂量及多剂量给药的比较生物利用度和效应研究。
Acta Pharmacol Toxicol (Copenh). 1975;36(Suppl 5):45-58. doi: 10.1111/j.1600-0773.1975.tb03321.x.
5
The effects of propranolol, practolol and metoprolol on exercise-induced tachycardia in relation to plasma levels in man.普萘洛尔、心得宁和美托洛尔对人体运动诱发心动过速的影响及其与血浆水平的关系。
Clin Exp Pharmacol Physiol. 1976 Sep-Oct;3(5):473-82. doi: 10.1111/j.1440-1681.1976.tb00625.x.
6
A comparison of slow release with conventional oxprenolol: plasma concentrations and clinical effects.缓释氧烯洛尔与传统氧烯洛尔的比较:血浆浓度及临床效果
Br J Clin Pharmacol. 1976 Jun;3(3):439-43. doi: 10.1111/j.1365-2125.1976.tb00619.x.
7
Pharmacokinetic and pharmacodynamic studies with long-acting propranolol.长效普萘洛尔的药代动力学和药效学研究。
Br J Clin Pharmacol. 1978 Aug;6(2):115-21. doi: 10.1111/j.1365-2125.1978.tb00835.x.
8
Beta-blockers: once or three times a day?β受体阻滞剂:一日一次还是一日三次?
Br Med J. 1978 May 27;1(6124):1386-8. doi: 10.1136/bmj.1.6124.1386.
9
Plasma levels and effects of metoprolol on blood pressure and heart rate in hypertensive patients after an acute dose and between two doses during long-term treatment.急性给药后及长期治疗期间两剂之间美托洛尔在高血压患者中的血浆水平及其对血压和心率的影响。
Clin Pharmacol Ther. 1975 Apr;17(4):400-8. doi: 10.1002/cpt1975174400.
10
The assessment of beta-adrenoceptor blocking drugs in man.人体中β-肾上腺素能受体阻断药物的评估。
Br J Clin Pharmacol. 1977 Aug;4(4):413-25. doi: 10.1111/j.1365-2125.1977.tb00756.x.